Keytruda Adjuvant Kidney Cancer Data Cement The Future Of IO

“Practice Changing” KEYNOTE-564 Data Presented At ASCO Plenary

 
• By Alaric DeArment
Human kidney on scientific background. 3d illustration
Merck & Co. presents "practice changing" data on Keytruda in adjuvant renal cell carcinoma • Source: Shutterstock

More from ASCO

More from Conferences